Signed by Governor Ron DeSantis

Vote Smart's Synopsis:

Vote to concur with Senate amendments and pass a bill that expands the list of medical conditions that pharmacists may treat in an emergency.

Highlights:

• Establishes a collaborative pharmacy practice agreement program between eligible pharmacists and physicians (Sec. 3).

• Requires collaborative pharmacy practice agreements to include the following (Sec. 3):

• The collaborating physician’s patients’ names;

• Each chronic health condition to be collaboratively managed;

• Specific medicinal drugs to be managed by the pharmacist;

• Circumstances under which the pharmacist may order or perform laboratory tests;

• Conditions upon which the pharmacist must notify the physician and the timeframe in which a notification must occur;

• Beginning and ending dates for the agreement and termination procedures; and

• A statement that the agreement may be terminated by either party at any time.

• Defines “chronic health conditions” as any of the following (Sec. 3):

• Arthritis;

• Asthma;

• Chronic obstructive pulmonary diseases;

• Type 2 diabetes;

• HIV/AIDS;

• Obesity; or

• Any other chronic condition adopted by the Board of Medicine and Board of Osteopathic Medicine.

• Authorizes pharmacists in a collaborative pharmacy practice agreement to provide specified patient care services to a physician’s patients (Sec. 3).

• Specifies that a collaborative pharmacy practice agreement expires 2 years after execution if not renewed (Sec. 3).

• Authorizes pharmacists to test for and treat any of the following health conditions (Sec. 4):

• Influenza;

• Strep throat;

• Lice;

• Athlete’s foot; and

• Minor, uncomplicated infections.

• Specifies that this bill takes effect on July 1, 2020 (Sec. 5).

Full Bill Text

Vote Smart's Synopsis:

Vote to amend and pass a bill that expands the list of medical conditions that pharmacists may treat in an emergency.

Highlights:

• Establishes a collaborative pharmacy practice agreement program between eligible pharmacists and physicians (Sec. 3).

• Requires collaborative pharmacy practice agreements to include the following (Sec. 3):

• The collaborating physician’s patients’ names;

• Each chronic health condition to be collaboratively managed;

• Specific medicinal drugs to be managed by the pharmacist;

• Circumstances under which the pharmacist may order or perform laboratory tests;

• Conditions upon which the pharmacist must notify the physician and the timeframe in which a notification must occur;

• Beginning and ending dates for the agreement and termination procedures; and

• A statement that the agreement may be terminated by either party at any time.

• Defines “chronic health conditions” as any of the following (Sec. 3):

• Arthritis;

• Asthma;

• Chronic obstructive pulmonary diseases;

• Type 2 diabetes;

• HIV/AIDS;

• Obesity; or

• Any other chronic condition adopted by the Board of Medicine and Board of Osteopathic Medicine.

• Authorizes pharmacists in a collaborative pharmacy practice agreement to provide specified patient care services to a physician’s patients (Sec. 3).

• Specifies that a collaborative pharmacy practice agreement expires 2 years after execution if not renewed (Sec. 3).

• Authorizes pharmacists to test for and treat any of the following health conditions (Sec. 4):

• Influenza;

• Strep throat;

• Lice;

• Athlete’s foot; and

• Minor, uncomplicated infections.

• Specifies that this bill takes effect on July 1, 2020 (Sec. 5).

Full Bill Text